Performance evaluation of Elecsys analysis system for anti-cyclic citrullinated peptide detection in comparison with commercially available ELISA assays in rheumatoid arthritis diagnosis.
Cai B, Wang L, Liu J, Feng W
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of detection method on the measurement of anti-CCP in patients with RA, other autoimmune diseases, involution diseases, and in healthy controls.
Summary of Findings
Anti-CCP levels were higher in RA patients than in normal controls or non-RA patients (p< 0.05). The diagnostic accuracy for RA of the Euroimmun ELISA, Euro-diagnostica ELISA, and the Elecsys analyzer were and 76.39%, 77.08% and 77.78% respectively. Anti-CCP levels were higher when measured using the Euro-diagnostica ELISA or the Elecsys analyzer than with the Euroimmun ELISA. There was no correlation of anti-CCP with CRP levels. One of 9 patients with osteoarthritis and 1 of 2 with scleroderma tested positive for anti-CCP using all three assays, and 1 of 4 patients with polymyositis tested positive using the Euroimmun ELISA. There was no significant effect of assay type on the area under the specificity versus sensitivity plots. Using the manufacturers cut-off values, the sensitivity for anti-CCP detection was highest using the Elecsys assay (67.74%) and the specificity was greatest using the Elecsys assay or the Euro-diagnostica ELISA (both 92.86%). Use of the optimal cut-off values for each assay increased the specificity but sensitivity was only increased for the Elecsys assay.
Biospecimens
FluidSerumFluidBloodPreservation Types
FrozenDiagnoses
LupusNormalOsteoarthritisRheumatoid ArthritisOther diagnosesOsteoporosisPlatforms
ProteinELISAProteinClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Ankylosing spondylitisOsteochondritisPolymyositisSclerodermaSystemic sclerosisELISA Specific Targeted peptide/protein CRPanti-CCPClinical chemistry/auto analyzer Specific Technology platform Euro-diagnostica ELISAEuroimmun ELISA